# Mark Lynch

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mark-lynch/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,293 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 36 |
| i10-index | 71 |
| OpenAlex ID | https://openalex.org/A5022430976 |
| ORCID iD | https://orcid.org/0000-0002-8476-4854 |
| Works | 133 |

## Researcher papers

- [Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck](https://scholariq.org/papers/nivolumab-for-recurrent-squamous-cell-carcinoma-of-the-head-and-neck/)
- [BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis](https://scholariq.org/papers/bay-43-9006-exhibits-broad-spectrum-oral-antitumor-activity-and-targets-the-raf/)
- [Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression](https://scholariq.org/papers/nivolumab-vs-investigator-s-choice-in-recurrent-or-metastatic-squamous-cell/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Head and Neck Cancer Studies](https://scholariq.org/topics/head-and-neck-cancer-studies/)
- [Single-cell and spatial transcriptomics](https://scholariq.org/topics/single-cell-and-spatial-transcriptomics/)
- [Clostridium difficile and Clostridium perfringens research](https://scholariq.org/topics/clostridium-difficile-and-clostridium-perfringens-research/)
- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.